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Objective: The objective of this study was to quantify the relationship between number of dental amalgam
surfaces and urinary mercury levels.
Methods: This study uses participant data from a large philanthropic chronic disease prevention program in
Calgary, Alberta, Canada. Urine samples were analysed for mercury levels (measured in μg/g-creatinine). T-tests
were used to determine if differences in urine mercury were statistically significant between persons with no dental
amalgam surfaces and one or more dental amalgam surfaces. Linear regression was used to estimate the change in
urinary mercury per amalgam surface.
Results: Urinary mercury levels were statistically significantly higher in participants with amalgam surfaces, with an
average difference of 0.55 μg/g-creatinine. Per amalgam surface, we estimated an expected increase of 0.04 μg/
g-creatinine. Measured urinary mercury levels were also statistically significantly higher in participants with dental
amalgam surfaces following the oral administration of 2,3-dimercaptopropane-l-sulfonate (DMPS) and meso-2,3-
dimercaptosuccinic acid (DMSA) which are used to mobilize mercury from the blood and tissues.
Discussion: Our estimates indicate that an individual with seven or more dental amalgam surfaces has 30% to 50%
higher urinary mercury levels than an individual without amalgams. This is consistent with past literature that has
identified seven amalgam surfaces as an unsafe level of exposure to mercury vapor. Our analysis suggests that
continued use of silver amalgam dental fillings for restorative dentistry is a non-negligible, unnecessary source of
mercury exposure considering the availability of composite resin alternatives.
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Amalgam dental surfaces are popular in dentistry and
have been for decades. They contain approximately 50%
mercury in combination with other metals including sil-
ver and copper [1]. The widespread use of amalgam sur-
faces can be attributed to their low cost and high
durability compared to other types of surfaces. However,
the use of dental amalgams has always been a source of
controversy because of the potential health risks associ-
ated with exposure to mercury. The main concern over
dental amalgams is the inhalation of mercury vapor from* Correspondence: duttond@ucalgary.ca
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reproduction in any medium, provided the orthe surface, possibly leading to increased mercury levels
in the body [1]. Richardson notes that viable alternative
(non-Hg) restorative materials like composite resins
exist, making reliance on dental amalgam for the restor-
ation of carious teeth no longer necessary or essential
[2]. This in turn means that continued use of dental
amalgams for restorative dental care is a source of un-
necessary exposure to mercury vapor which has been
shown to exceed the safe level of mercury exposure
when an individual has seven or more dental amalgam
surfaces [2].
A sizeable body of research suggests that dental amal-
gams are a major source of mercury exposure in the
general population, with several studies showing a cor-
relation between the number of amalgam surfaces andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[3-13]. For example, it has been estimated that for every
10 amalgam surfaces an individual has, there is a corre-
sponding increase in urinary mercury concentrations of
approximately one μg/L, roughly doubling normal back-
ground concentrations [11]. Dental amalgams have also
been correlated with disease outcomes, for instance, kid-
ney function in children [14] or neurological degener-
ation in adults (e.g., Alzheimer’s disease) [15]. High
levels of mercury in the diet, an allergy to mercury, im-
paired kidney function, and environmental or workplace
exposure to mercury are all contraindications for dental
amalgams according to Health Canada [16,17].
However, evidence to date is mixed, with some studies
asserting that mercury levels are not elevated in those
with dental amalgams, or that any observed elevations
were not associated with health impacts [18-20]. The ac-
cumulated evidence on amalgam surfaces and the rela-
tionship with mercury levels is based on many small
studies and few large studies, so it is possible that the
wide-ranging conclusions in the literature are partly due
to small sample sizes.
Recent Canadian estimates from a large, population-
based sample show that, for Canadians with dental amal-
gams, over 80% are exposed to more mercury daily than
the current government guidelines recommend [2]. This
estimate was based on extrapolation from the number of
observed amalgam surfaces per individual, and states
that seven or more amalgams in an adult will lead to
higher than recommended mercury levels per unit of
body weight.
The objective of this study is to estimate the relation-
ship between the number of amalgam surfaces and urin-
ary mercury levels. We take advantage of a large sample
of men and women with two measures for urinary ex-
cretion of mercury and number of amalgam surfaces.
We find that individuals with one or more dental amal-
gam surfaces have, on average, at least double the urin-
ary mercury level of individuals with no dental amalgam
surfaces. We find a statistically significant linear rela-
tionship between urinary mercury levels and the number
of amalgam surfaces. The magnitude of the exposure
that we identify is consistent with past literature that has
identified 7 amalgam surfaces as an unsafe level of ex-
posure to mercury vapor [18]. Safety levels remain un-
defined for long-term, low-dose mercury exposure, but
our analysis suggests that continued use of silver amal-
gam dental fillings results in higher mercury exposure
that could be avoided with alternative filling materials.
Methods
Participants
Participants were drawn from enrollees in the Pure
North S’Energy Foundation program (henceforth “PureNorth”), which is a philanthropic wellness and chronic-
disease prevention program based in Calgary, Alberta,
Canada. Pure North assesses participant health status
using questionnaires, biometric measurements and la-
boratory tests to provide personalized preventive health
care services. Healthcare workers at Pure North (includ-
ing nurses, doctors, and dentists) provide participants
with lifestyle counselling, dietary supplementation with
vitamins, minerals and other nutrients and dental care.
There is no cost to the participants for the services of-
fered - this includes dental care. As part of the health
assessment, Pure North physicians assess the number
of dental amalgam surfaces in an individual’s mouth
and offer participants the option to test their urine
mercury levels. We report data from 2,137 subjects
from September 2010 through February 2013 who
agreed to undergo a urinary six hour challenge to deter-
mine their mercury levels.
Data collection
Dentists inspected participant’s mouths and oral x-rays
to determine the number of amalgam fillings and sur-
faces. Typical molars have five surfaces, and conse-
quently, there can be several amalgam surfaces per filled
tooth (on average, there are 2 amalgam surfaces per
filled tooth) [2]. Demographic and lifestyle information
were obtained from health questionnaires routinely com-
pleted by Pure North participants. Height, weight, waist
circumference and blood pressure were collected by the
medical staff.
There are two measures of urinary mercury levels col-
lected by Pure North. First, urine mercury levels are
measured in a urine sample requiring no special consid-
erations. Program participants are also offered the op-
portunity to undergo a 6 hour urinary challenge test for
toxic metals (UTM challenge) which involves collecting
urine for 6 hours following the oral administration of
30 mg 2,3-dimercaptopropane-l-sulfonate (DMPS) and
500 mg meso-2,3-dimercaptosuccinic acid (DMSA).
DMPS and DMSA can be used to mobilize mercury from
the blood and tissues and has been shown to significantly
increase urinary excretion of mercury following a single
administration [19]. While it remains unclear to what ex-
tent a single administration of DMSA and DMPS will
mobilize stores of mercury in the brain, kidney and organs
[19], it has been suggested that the use of this type of urin-
ary challenge for the determination of urinary mercury
levels increases the significance and reliability of urine
levels as a measurement of mercury exposure and net
bodily retention [18].
Post challenge with DMPS and DMSA, urine was col-
lected in a 2.5-l polypropylene sampling vessel and a
sample was collected from this vessel. The two collected
urine samples were then sent to Doctor’s Data, Inc.
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testing. Analysis of urinary elements was performed by
ICP-Mass Spectroscopy following acid digestion of the
specimen. Urinary mercury concentrations are reported as
μg/g-creatinine to reduce error introduced by variation in
sample volume.Variables & statistical analysis
The primary outcome measures were urinary mercury
levels measured from samples from the initial appoint-
ment and following the UTM challenge. Exposure to
mercury was estimated based on the number of amal-
gam surfaces. Participant characteristics included age,
sex, height, weight (expressed as tertiles), and BMI.
Analyses were completed using Stata 11. The variables
used in this analysis were summarized with means and
standard deviations if they were continuous variables
and with percentages if they were binary or categorical
variables. Comparisons of the average mercury levels by
amalgam group were conducted with t-tests. We then
used ordinary least squares regression models to investi-
gate the association between mercury levels, amalgams,
and patient characteristics. The initial model included
age, sex, height in metres, weight in kilograms
(expressed as tertiles), and BMI (weight/height2). For all
tests of significance, we used a significance level of five
percent to determine evidence of an association. Ethics
approval for this study was obtained from the University
of Calgary (Ethics ID E-24890).Results
Characteristics of the participants are reported in Table 1.
The distribution of the number of surfaces per participant
is presented in Figure 1. For participants with amalgams,










Age in Years: Mean (sd) 49.3 (11.6) 49.7 (11.9) 48.9 (11.3)
1 or More Amalgams 73% 80% 67%
Mean Number of Amalgam
Surfaces, inclusive of zero
surfaces (sd)
12.8 (13.6) 14.4 (13.7) 11.4 (13.3)
Weight in kg: Mean (sd) 80.5 (17.4) 73.6 (16.8) 86.5 (15.6)
Weight <74kg 40% 61% 22%
Weight 74-90kg 33% 22% 41%
Urinary Hg (μg/g-creatinine):
Mean (sd)
1.3 (1.8) 1.7 (2.3) 1.0 (1.2)
Urinary Challenge Hg
(μg/g-creatinine): Mean (sd)
9.6 (12.9) 12.9 (15.1) 6.8 (9.9)
Notes: sd standard deviation.Comparing those with and without dental amalgams, we
find statistically significant mean differences in both urin-
ary mercury measures. Urinary mercury levels in partici-
pants with amalgams are 0.55 μg/g-creatinine higher, or
64% greater, than the mean of 0.86 μg/g-creatinine for
participants without amalgams. UTM challenge urinary
mercury levels for participants with one or more dental
amalgam surfaces are on average five μg/g-creatinine
higher – almost double – the mean of 5.32 μg/g-creatinine
for those participants with no amalgam surfaces.
Figure 2 shows the distribution of mercury levels for
those with and without mercury amalgams and Figure 3
shows the same comparison using the UTM challenge
urinary mercury measure. In both figures the median
levels of μg/g-creatinine are nearly double for those with
one or more amalgams than participants with no amal-
gam surfaces. The median mercury level for those
with one or more dental amalgam surfaces was 1.1 μg/
g-creatinine, versus 0.6 μg/g-creatinine for those with no
amalgams. Meanwhile, the median UTM challenge urin-
ary mercury level for those with amalgams was 6.3 μg/
g-creatinine versus 2.75 μg/g-creatinine for those with
no amalgam surfaces. Individuals with amalgams
exhibited, in some cases, very high levels of mercury:
there are more outliers in the amalgam surfaces group
than the group without amalgam surfaces.
The results for the model of mercury levels, number
of amalgams, and participant demographics are pre-
sented in Table 2. There was statistical evidence that sex
and weight were associated with baseline and UTM
challenge urinary mercury levels. With these characteris-
tics and exposures in the model, there was no evidence
that height, BMI or age confounded the relationship be-
tween amalgam surfaces and urinary mercury levels.
The coefficient estimate for the per-amalgam surface
increase in urinary mercury of 0.04 ug/g-creatinine is
statistically significant. For males and females of mean
weight in the sample, this per surface increase represents
a 5% and 3% increase in ug/g-creatinine over the base-
line level for someone with no amalgam surfaces. For
the UTM challenge urinary mercury measures, the per
surface effect of 0.32 ug/g-creatinine represents 9% and
4% increases over the ug/g-creatinine for someone with
no amalgam surfaces.
Discussion
We find a statistically significant association between
amalgam surfaces and two measures of urinary mercury
levels. Other researchers have examined the relationship
between amalgam surfaces and urinary concentrations
[4,6-10,13] but only two [18,20] have specifically exam-
ined UTM challenge urine mercury levels, with mixed
results. Aposhian et al. measured mercury excretion nine
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Figure 1 Frequencies of the number of amalgam surfaces in study participants.
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[18]. They found that individuals with amalgams ex-
creted roughly 3 times more mercury after DMSA than
those without amalgams and that there was a statistically
significant positive relationship between mercury excre-
tion and total amalgam surface area. In contrast, Vamnes
et al. found no significant relationship between number
of amalgam surfaces and urinary mercury excretion fol-
lowing DMPS injection in 41 patients, although they
note that subjects in the study were relatively similar in
terms of number of amalgams [20]. In both cases the
conclusions that could be drawn from these studies were
limited by their small sample sizes. A main strength of























One or more amal
Figure 2 Frequencies of urine mercury levels in those with and withoon over 2000 individual participants. This much larger
sample size enabled us to determine the relationship be-
tween amalgam surfaces and urinary concentration while
considering other confounders mentioned in the
literature.
Exposure to mercury vapor is a known health risk with
no clearly established safe level of exposure. Health
Canada has previously acknowledged that dental amal-
gam is the single largest source of mercury exposure for
the average Canadian but assesses that other than for
the two to three percent of the population with mercury
allergies or hypersensitivity, evidence does not indicate
that dental amalgam exposures are high enough to cause
illness [21]. Compared to the urinary mercury levelercury levels
gams No amalgams
ut amalgams.
Figure 3 Frequencies of urine challenge mercury levels in those with and without amalgams.
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g-creatinine, our estimates of elevated urinary mercury
due to amalgam surfaces are well below that level and
would be considered “not harmful” by Health Canada.
Chronic exposure to low doses of mercury from dental
amalgam is difficult to evaluate from a health safety per-
spective and there is no established level of mercury ex-
posure considered safe or unsafe over longer periods of
time. The Tolerable Daily Intake (TDI) concept for ex-
posure to hazardous substances defines a level of expos-
ure “to which people could be exposed continuously
over their lifetime without suffering any harmful effects”.
TDI’s for mercury are based on exposures from indus-
trial and environmental sources [21]. Mercury vapor
doses from dental amalgam fillings by industrial stan-
dards are considered to be small at any given point in
time, but given that exposure to amalgams is essentially
lifelong it can be argued that the current thresholds for
mercury exposure should be lowered [22]. Recent re-
search on rats has speculated on particular mechanisms
through which low, constant exposure to mercury nega-
tively affected body systems [23,24]. A review on the
health of humans and low levels of mercury concludedTable 2 Factors associated with urine mercury levels
Unprovoked mercury (μg/g-creatinine)
Effect 95% CI
Baseline Level 0. 470 μg/g 0.314, 0.627 <
Per Surface 0.04 μg/g 0.03, 0.04 <
< 74 kg* 0.30 μg/g 0.10, 0.49
74 to 90 kg* 0.15 μg/g −0.04, 0.34
Female vs Male 0.52 μg/g 0.31, 0.63 <
* baseline group: >90 kg. Other than the baseline level, the effect indicates the unithat the evidence base was too small to quantify the risk
of chronic exposure to mercury [25].
According to Richardson, individuals with seven amal-
gam surfaces or more would be experiencing levels of
urinary mercury that correspond to exposures above the
federal government’s recommendation for safe levels of
mercury vapor [2]. Our estimates of the per-amalgam
surface increase in μg/g-creatinine are consistent with
the ranges estimated by Richardson for the Canadian
population (if not slightly higher) using the Canadian
Health Measures Survey, thus, the mercury exposure
levels associated with amalgams estimated by Richardson
can be used with our data [2]. Our model shows that
seven amalgam surfaces would be expected to increase
urinary mercury levels by 36% over that of an average
male with no amalgam surfaces and by 22% over that of
an average weight female with no amalgam surfaces. For
the UTM challenge urinary mercury measure, compared
to no amalgam surfaces, having seven surfaces would in-
crease the urinary mercury concentration by 65% in
males of mean weight for the sample and 30% in females
of mean weight for the sample. As the mean number of
amalgam surfaces observed in our dataset was 12.8, theProvoked mercury (μg/g-creatinine)
P Effect 95% CI P
0.001 1.73 μg/g 0.657, 2.806 <0.001
0.001 0.32 μg/g 0.28, 0.35 <0.001
0.002 3.41 μg/g 2.11, 4.73 <0.001
0.118 1.69 μg/g 0.40, 2.97 0.015
0.001 4.14 μg/g 3.04, 5.24 <0.001
t increase in mercury level associated with each participant characteristic.
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posure to mercury vapor that Richardson has shown to
be above Health Canada’s recommended safe level [2].
Given this clear association between amalgam surfaces
and urinary mercury levels, it is important for future re-
search to address the impact that mercury vapor expos-
ure from amalgam surfaces may have on health
outcomes. The continued widespread use of amalgams
could be causing negative health consequences in the
Canadian population. Dental amalgam has a unique
regulatory treatment. Health Canada describes dental
filling materials as being classified as medical devices
under the Medical Devices Regulations of the Food and
Drugs Act and the authority of that act applies to sale of
the device but not its use by dentists. Where medical
devices to be implanted in the body must pass a pre-
market review of safety and efficacy data, dental mate-
rials including amalgam are exempted from this review
since they had been on the market before the enactment
of the safety regulation. Consequently, dental amalgam
remains in use until evidence of harm to health is pro-
duced as opposed to the usual practice of not being in
use until evidence of safety is produced [21].
Health Canada’s 1996 Position Statement on Dental
Amalgam assessed that there was not sufficient evidence
to support a total ban on amalgam or the removal of
sound amalgam fillings in patients who have no indica-
tion of adverse health effects attributable to mercury ex-
posure. Even in the absence of clinical evidence of
adverse health effects, Health Canada did recommend
reducing exposure to heavy metals provided the reduc-
tions can be achieved “at reasonable cost and without
introducing other adverse effects”. Health Canada
recommended the avoidance of amalgam fillings for pri-
mary teeth of children, for pregnant women and people
with kidney disease. Health Canada also recommended
that dentists provide patients with sufficient information
on the risks and benefits of dental materials for filling
teeth so that patients can make informed choices about
what to have implanted in their mouths. Health Canada
also expressed that dentists should acknowledge the pa-
tient’s right to decline treatment with any dental
material.
There was a good deal of unexplained variation in our
model. Even with the inclusion of additional patient
characteristics and exposures, the model was only able
to account for approximately 10% to 22% of the vari-
ation in the baseline urinary and post challenge urinary
mercury levels. This variation could be due to a number
of factors, including unmeasured exposures, measure-
ment error, how many years the amalgam has been in
the bearer’s mouth, the condition of the amalgam from
wear and tear and metabolic factors. Research has shown
that there are many genetic polymorphisms in the genesfor enzymes and proteins involved in the detoxification
and elimination of heavy metals, and that this can influ-
ence mercury levels. Variations in the genes for glutathi-
one related enzymes and selenoproteins have both been
shown to significantly influence inter-individual varia-
tions in mercury retention, elimination and overall mer-
cury burden [26]. There is also evidence that gum
chewing (especially nicotine gum) can increase mercury
levels in persons with mercury amalgams. In addition,
there may be numerous possible environmental sources,
including fluorescent light bulbs, consumption of large
fish, and electronics. The fact that the number of dental
amalgam surfaces has a sizeable statistically significant
correlation with urinary mercury levels across many in-
dividuals means that even without explaining total vari-
ation in mercury levels we can identify an important
source of mercury exposure.
One limitation of our study is that, in general, it is dif-
ficult to interpret the meaning of post challenge urine
levels. The UTM challenge used to obtain the second
urine measure analysed in this study will draw mercury
from blood and other tissues. To our knowledge, only
one study has examined the relationship between UTM
challenge urinary mercury concentrations and blood
mercury levels [21]. In addition, the impact of metal
binding agents used for the UTM challenge may vary
from person to person and participants may have made
errors in the urine collection. Furthermore, differences
in urine flow rate, which is affected by fluid intake and
time of day, could impact mercury concentration in the
urine. Trachtenberg et al. found that increased urine
flow rate was associated with a significant decrease in
mercury concentration and a non-significant increase in
mercury excretion rate [27]. However, the mercury/cre-
atinine ratio was unaffected by flow rate, suggesting that
using creatinine-corrected mercury concentrations could
compensate for differences in flow-rate or fluid intake.
Furthermore, all measures of mercury significantly in-
creased with the number of amalgam surfaces, regardless
of variation due to flow-rate. Thus, despite these draw-
backs, our large sample size provides convincing evi-
dence of a statistically important association between
dental amalgam surfaces and urinary mercury levels.
Another limitation to our study is that we are unable
to measure the age of the amalgam surfaces in partici-
pants. It has been shown that as an amalgam surface
ages the amount of mercury contained in the surface de-
creases due to chemical change [28]. While the average
age of participants in our study is approximately 49
years, it is possible that some of the amalgam surfaces
observed were new and thus gave off more mercury than
the average amalgam surface. More likely, considering
the average age of participants, is that the amalgam sur-
faces we observed are older and thus the mercury levels
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ure associated with the average aged amalgam surface.
This means that our estimate of an unsafe number of
amalgams, which we derived from a previously published
study [2], may apply only to older and less potent amal-
gam surfaces.
Our study does not discuss the effect on mercury urine
of amalgam removal. Individuals with zero amalgam sur-
faces have lower urine mercury levels than individuals
with one or more amalgam surfaces. However, that does
not imply that removing amalgams from the amalgam
group will result in urine mercury levels similar to individ-
uals without amalgams. Some studies have shown that re-
moving amalgams is associated with a temporary spike in
mercury levels at the time of removal, after which mercury
levels tend to decrease to levels below the pre-removal
mercury level; that spike that is attributed to agitation of
the mercury in the dental amalgam [29,30].
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